Timing matters in combination therapy
Sign Up to like & getrecommendations! Published in 2020 at "Science Signaling"
DOI: 10.1126/scisignal.abb5803
Abstract: Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy. Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy. read more here.
Keywords: timing matters; combination therapy; matters combination;